Skip to main content
Full access
Letters
Published Online: 1 January 2014

Refractory Schizo-Obsessive Disorder Responsive to Electroconvulsive Therapy

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences
To the Editor: Approximately 2%−3% of the world’s population suffers from obsessive-compulsive disorder (OCD), a prevalence that is constant across cultures. Despite advances in psychopharmacology and the approval of selective serotonin reuptake inhibitors (SSRIs) for treatment of OCD, 40%−60% of patients with OCD show limited to no improvement while using them.1

Case Report

“Mr. C” is a 25-year-old man with a history of OCD since 12 years of age and was brought to the emergency room for worsening self-injurious behavior, suicidal gestures of taking an extra tablet of diazepam, and ongoing conviction that the devil was trying to rape him. History was difficult to obtain from the patient due to ego-dystonic fixation on intrusive graphic sexual images and circumstantial thought processes. He exhibited high levels of anxiety and tearfulness, minimal eye contact, and psychomotor agitation. His thought content was notable for hyper-religiosity, thought insertion, and ego-dystonic sexual ruminations. He failed trials of cognitive-behavioral therapy (CBT), fluvoxamine, aripiprazole, venlafaxine, olanzapine, fluoxetine, diazepam, quetiapine, and risperidone. He denied use of nicotine, alcohol, or illicit drugs.
While an inpatient, he received three bitemporal ECT treatments at 0.5 pulse width, 30 Hz, 2.0-second duration, and 800 mA, and noted continued anxiety, but he was able to sit quietly and answer questions with linearity and logic. He was discharged to continue five more ECT treatments followed by maintenance therapy and medication management including diazepam, fluoxetine, and quetiapine. All involved reported significant reduction in intensity of intrusive thoughts and an increased ability to maintain orientation and memory, although he continues to exhibit anxiety. Mr. C is taking greater pleasure in activities and has not had any adverse cognitive effects, has been employed, and now works 5 days per week.

Discussion

This patient presented a unique diagnostic challenge in differentiating intrusive thoughts with poor insight as a part of OCD from thought insertion due to a psychotic disorder. He met DSM-IVR criteria for both OCD and schizophrenia (DSM-IVR). As many as one-quarter of persons with schizophrenia also have OCD2; Hwang and Hollander use the term “schizo-obsessive.”3 Although SSRIs are first-line treatment, more than half of patients have limited to no improvement while using them.1 The landmark retrospective study on the use of ECT for OCD was published by Maletzky et al.; schizo-obsessive disorder appears to be responsive to ECT.4 There are at least two previous case reports of coexistent OCD and schizophrenia being treated successfully with ECT.5,6
This report, when considered with other reports of successful treatment of OCD with ECT, suggests that ECT may be a viable therapy for severe refractory OCD.

References

1.
Marazziti D, Consoli G: Treatment strategies for obsessive-compulsive disorder. Expert Opin Pharmacother 2010; 11:331–343
2.
Tibbo P, Kroetsch M, Chue P, et al: Obsessive-compulsive disorder in schizophrenia. J Psychiatr Res 2000; 34:139–146
3.
Hwang MY, Hollander E: Schizo-obsessive disorders. Psychiatr Ann 1993; 23:396–401
4.
Maletzky B, McFarland B, Burt A: Refractory obsessive compulsive disorder and ECT. Convuls Ther 1994; 10:34–42
5.
Chaves MP, Crippa JA, Morais SL, et al: Electroconvulsive therapy for coexistent schizophrenia and obsessive-compulsive disorder. J Clin Psychiatry 2005; 66:542–543
6.
Lavin MR, Halligan P: ECT for comorbid obsessive-compulsive disorder and schizophrenia. Am J Psychiatry 1996; 153:1652–1653

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: E15
PubMed: 26037871

History

Published online: 1 January 2014
Published in print: Fall 2014

Authors

Details

Erik Johnson, M.D.
Eastern Virginia Medical School, Norfolk, VA (EJ, S Peglow, S Patel); and Hampton Veterans Affairs Medical Center, Hampton, VA (CD)
Stephanie Peglow, D.O.
Eastern Virginia Medical School, Norfolk, VA (EJ, S Peglow, S Patel); and Hampton Veterans Affairs Medical Center, Hampton, VA (CD)
Shriti Patel, M.D.
Eastern Virginia Medical School, Norfolk, VA (EJ, S Peglow, S Patel); and Hampton Veterans Affairs Medical Center, Hampton, VA (CD)
Christian DeFilippo, M.D.
Eastern Virginia Medical School, Norfolk, VA (EJ, S Peglow, S Patel); and Hampton Veterans Affairs Medical Center, Hampton, VA (CD)

Notes

Correspondence: Stephanie Peglow, D.O.; e-mail: [email protected]

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share